News

A team of researchers from Japan found that Alzheimer’s symptoms can be reduced when sugars are averted from binding to one of the disease key enzymes, named BACE1. The study entitled “An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer’s disease“, was published…

On December 2014, scientific experts in the fields of both cardiovascular diseases and Alzheimer’s disease (AD) met in Chicago to discuss the link between vascular risk factors and dementia in AD. The event was organized by the Alzheimer’s Association, with scientific input from the National Institutes of Health’s National…

Patients receiving treatment to correct or control atrial fibrillation, and end up being “overtreated” for a long period of time with anti-clotting medication warfarin, in combination with antiplatelet treatments aspirin or clopidigrel, may have an increased risk of developing dementia or Alzheimer’s disease according to a study presented at the American Heart Association’s…

A team of researchers from Australia aimed to determine the occurrence of eating abnormalities in subtypes of frontotemporal dementia (FTD) besides the well established behavioral variant of frontotemporal dementia (bvFTD). The study entitled “Quantifying the Eating Abnormalities in Frontotemporal Dementia”, was recently published in…

A research team from the Wake Forest Baptist Medical Center developed a form of insulin intended to be delivered via nasal spray that can have positive results on mental capabilities, such as the working memory of adults suffering from Alzheimer’s disease and other mental and cognitive impairments. The study examined the nasal spray’s effects on 60 adults diagnosed with amnesic mild…

Neurodegenerative diseases such as Alzheimer’s can provoke a neural dysfunction that affects the patient’s behavior, leading to criminality. This is according to a research recently published in the journal JAMA Neurology. Despite the concerning results, the scientists noted that Alzheimer’s patients were among the least likely to developing…

A team of researchers from Scandinavia conducted a study, titled, “The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress,” now published in Alzheimer’s & Dementia – the journal of the Alzheimer’s Association. It evidenced physical activity, cognitive…

An important victory for Alzheimer’s disease patients advocates occurred last month when the U.S. Congress approved legislation that can significantly increase the federal budget allotted for research and development on newer and better approaches to prevent and treat this common form of dementia. Larisa Kofman, the public policy director for the Alzheimer’s Association’s Oregon…

The in-home care provider for seniors in the U.S. and Canada, Home Care Assistance of Toronto, is organizing an event to launch its Cognitive Therapeutics Method (CTM) in Ontario. The proprietary science-based cognitive stimulation program, designed to be administrated in patients’ homes, will be discussed by…

 A new study established a Self-Administered Gerocognitive Examination (SAGE) as a screening tool for mental decline, as observed in neurological conditions such as Alzheimer’s disease. This study entitled “Community Cognitive Screening Using the Self-Administered Gerocognitive Examination (SAGE)” was published in The Journal of…